PHASE II: ADAPTIVE TREATMENT DE-ESCALATION IN FAVORABLE RISK HPV-POSITIVE OROPHARYNGEAL CARCINOMA

Brief description of study

PHASE II: ADAPTIVE TREATMENT DE-ESCALATION IN FAVORABLE RISK HPV-POSITIVE OROPHARYNGEAL CARCINOMA


Clinical Study Identifier: s17-00330
ClinicalTrials.gov Identifier: NCT03215719


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.